Our Take
The market size and customer need are real; the product thesis (calm-now, educate-later, tools-last) is credible but unproven at scale against entrenched competitors.
Why it matters
Digital mental health is a crowded, well-funded space. Anxiety Checklist's claim to combine crisis relief with education and structured therapy in one app suggests a different UX sequencing than meditation-first players, but no customer data or retention metrics are offered to validate the approach.
Do this week
If you're evaluating anxiety-management apps for employee or user deployment, request Anxiety Checklist's engagement cohort data and 90-day retention rates before committing—their positioning only describes the product experience, not the outcome.
Anxiety Checklist targets the therapy-access gap
Anxiety Checklist, led by CEO Romain Brabant, operates in the digital mental health market with a specific focus on anxiety and panic management. The company targets users who experience anxiety severe enough to prompt help-seeking but lack access to or can afford in-person therapy. The digital mental health market is already valued at over $20 billion globally and growing (company-reported), with anxiety disorders affecting approximately 300 million people worldwide.
The company's product approach differs from category incumbents. Rather than leading with meditation or general mindfulness, Anxiety Checklist sequences the user experience in three stages: immediate calm in moments of acute anxiety or panic, education about what's happening through a component called Anxiety University, and long-term behavior change using CBT-style tools and psychoeducation.
Brabant positions the app against two competitor categories. Meditation and wellness apps like Calm and Headspace dominate by user count and marketing spend. Anxiety-specific apps like There operate closer to Anxiety Checklist's focus but, according to the CEO, lack the integration of acute relief, education, and structured intervention.
The positioning is tight; the proof is absent
The market opportunity is substantial. Three hundred million people with anxiety disorders globally, a $20 billion addressable market, and a clear customer persona (anxious, motivated, financially constrained) form a rational foundation. The company correctly identifies a gap between on-demand crisis support and therapy access.
The product strategy is coherent and distinguishable. Sequencing calm-first prevents the user experience of confronting cognition or behavior work while in acute distress, which is a valid pedagogical choice that differs from meditation-app positioning and the generalist mental health categories.
What is missing is any public evidence of adoption, retention, or clinical outcome. No user count, cohort data, or longitudinal retention metrics appear in this interview. No independent validation of the three-stage sequencing versus a meditation-first or therapy-first model. No comparison of efficacy or user satisfaction against Calm, Headspace, or There. The CEO has articulated a hypothesis and a market; he has not yet demonstrated execution.
Request evidence before recommending
If you are responsible for mental health benefits, employee assistance programs, or user-facing mental health tools, do not assume the three-stage model outperforms meditation-first or therapy-first alternatives without data. Request Anxiety Checklist's cohort retention curves (30-day, 90-day), engagement metrics by user segment, and any independent clinical or user-satisfaction validation. The competitive narrative is clear; the outcome differential is not yet visible.